Detalles de la búsqueda
1.
[On the molecular drug design from viewpoint of precision medicine].
Yao Xue Xue Bao
; 52(1): 71-9, 2017 01.
Artículo
en Zh
| MEDLINE | ID: mdl-29911773
2.
[Drug innovation and reverse thinking].
Yao Xue Xue Bao
; 51(3): 325-31, 2016 03.
Artículo
en Zh
| MEDLINE | ID: mdl-29858888
3.
[Concise analysis for innovation of pioneering and follow-on drugs].
Yao Xue Xue Bao
; 51(8): 1179-84, 2016 08.
Artículo
en Zh
| MEDLINE | ID: mdl-29897709
4.
[Application of temperature sensitive yeast models with definite target in the screening of potential human Pin1 inhibitors].
Yao Xue Xue Bao
; 49(6): 854-60, 2014 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-25212032
5.
[Ligand efficiency and lead optimization].
Yao Xue Xue Bao
; 48(12): 1755-62, 2013 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-24689231
6.
[Challenges and strategies of drug innovation].
Yao Xue Xue Bao
; 48(7): 1031-40, 2013 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-24133969
7.
Small molecules targeting Pin1 as potent anticancer drugs.
Front Pharmacol
; 14: 1073037, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37050909
8.
[Modification of natural products for drug discovery].
Yao Xue Xue Bao
; 47(2): 144-57, 2012 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-22512023
9.
[Drug promiscuity].
Yao Xue Xue Bao
; 46(4): 361-9, 2011 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-21751487
10.
The synthesis of puerarin derivatives and their protective effect on the myocardial ischemia and reperfusion injury.
J Asian Nat Prod Res
; 12(10): 843-50, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20924897
11.
[Strategy of molecular drug design: activity and druggability].
Yao Xue Xue Bao
; 45(5): 539-47, 2010 May.
Artículo
en Zh
| MEDLINE | ID: mdl-20931752
12.
[Synthesis and activity of some new histone deacetylases inhibitors].
Yao Xue Xue Bao
; 45(6): 735-41, 2010 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-20939182
13.
Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.
Bioorg Med Chem Lett
; 19(8): 2270-2, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19286379
14.
[Strategy of molecular drug design: dual-target drug design].
Yao Xue Xue Bao
; 44(3): 209-18, 2009 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-19449516
15.
[Design of multiple targeted drugs].
Yao Xue Xue Bao
; 44(3): 276-81, 2009 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-19449524
16.
[Comparative pharmacophore analysis of dual dopamine D2/5-HT(2A) receptor antagonists].
Yao Xue Xue Bao
; 44(3): 314-20, 2009 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-19449530
17.
[Strategy of molecular drug design: hits, leads and drug candidates].
Yao Xue Xue Bao
; 43(9): 898-904, 2008 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-19048779
18.
[Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
Yao Xue Xue Bao
; 43(3): 227-33, 2008 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-18630256
19.
The modification of natural products for medical use.
Acta Pharm Sin B
; 7(2): 119-136, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28303218
20.
Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.
Protein Eng Des Sel
; 19(2): 47-54, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16339768